Zoroaher Liquid Wart Remover

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by a rough, cauliflower-like appearance on the surface, while plantar warts are identified by their location exclusively on the bottom of the foot, tenderness, and disruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed by soaking the wart in warm water for 5 minutes. After thorough drying, one drop of the medication should be applied at a time using an applicator to ensure sufficient coverage of each wart. Following application, the area should be allowed to dry completely. For additional concealment, self-adhesive masking sheets may be utilized to cover the warts.

This procedure may be repeated once or twice daily as needed, continuing until the wart is completely removed.

Contraindications

Use is contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions. Application on irritated skin or any area that is inflamed or reddened is also contraindicated, as it may worsen the irritation. Additionally, the product should not be applied to moles, birthmarks, warts with hair growth, genital warts, or warts located on the face or mucous membranes to avoid adverse reactions.

Warnings and Precautions

Use of this product is contraindicated in individuals with diabetes or poor blood circulation, as these conditions may exacerbate potential adverse effects. Application should be avoided on irritated skin or any areas that are inflamed or reddened, as this may lead to further irritation or complications. Additionally, the product must not be applied to moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes due to the risk of adverse reactions.

Healthcare professionals should advise patients to discontinue use and seek medical advice if discomfort persists. It is crucial to monitor for any signs of adverse reactions during treatment.

In the event of accidental ingestion, immediate medical assistance should be sought. Patients should be instructed to contact the Poison Control Center at 1-800-222-1222 without delay.

Side Effects

Patients with diabetes or poor blood circulation should exercise caution when using this product, as it may exacerbate their condition. The product is not recommended for application on irritated skin or any area that is inflamed or reddened. Additionally, it should not be used on moles, birthmarks, warts with hair growing from them, genital warts, or warts located on the face or mucous membranes.

In the event that discomfort persists after use, patients are advised to discontinue use and consult a healthcare professional for further guidance.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Zoroaher Liquid Wart Remover (salicylic acid 17% liquid wart remover). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 3 years of age should avoid using this product due to safety concerns. Additionally, caution is advised for use in children with allergies or those with damaged skin. Pregnant and lactating women are also advised against using this product.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and lactating women are advised to consult a healthcare professional prior to use. The use of this product is contraindicated in pregnant women, as well as in individuals with allergies, children under 3 years old, and those with damaged skin. The potential risks associated with use during pregnancy have not been fully established, and caution is warranted to avoid any adverse fetal outcomes. Therefore, it is recommended that pregnant patients refrain from using this product to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to use if they are pregnant or breastfeeding. It is recommended that lactating women avoid using this product, along with individuals with allergies, children under 3 years old, and those with damaged skin. There is no specific data available regarding excretion in breast milk or effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the situation.

Documentation of the incident, including the substance involved, estimated dose, and time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

Pregnant women, lactating women, individuals with allergies, children under 3 years old, and those with damaged skin should avoid using the product due to potential teratogenic effects. The product is intended for external use only and is flammable; it should be kept away from fire and flames.

No relevant information is available regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center at 1-800-222-1222 if the product is swallowed.

In the event that the product comes into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes to minimize potential irritation or damage.

It is important for patients to understand the necessity of securely capping the bottle when not in use and storing the product at room temperature, away from heat sources, to maintain its efficacy and safety.

Additionally, healthcare providers should counsel patients who are pregnant or breastfeeding to consult with a health professional prior to using the product, ensuring that they are aware of any potential risks or considerations.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 59-86°F (15-30°C). The product should be kept in a cool place, ensuring that it is protected from direct sunlight to maintain its integrity and efficacy. Proper handling and storage conditions are crucial for preserving the quality of the product.

Additional Clinical Information

The product is administered topically, with the procedure recommended to be repeated once or twice daily as needed until the wart is removed. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is also important to keep the product out of reach of children; in the event of ingestion, medical assistance should be sought immediately or the Poison Control Center contacted at 1-800-222-1222. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Zoroaher Liquid Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)